Skip to main content
Premium Trial:

Request an Annual Quote

Caprion Biosciences Buys Immune Monitoring Firm Serametrix

NEW YORK (GenomeWeb) – Caprion Biosciences said today that it has acquired immune monitoring firm Serametrix.

It said that the purchase will provide it access to Carlsbad, California-based Serametrix's expertise in analysis of myeloid-derived suppressor cells (MDSC) and its operations in the US, UK, Australia, and China.

"Joining forces with Serametrix enables Caprion to strengthen its immunology biomarker offering and provides CAP and CLIA-certified services for supporting Phase 1 through Phase 4 trials from seven different strategic locations in North America, Europe, and Asia," Caprion President and CEO Martin LeBlanc said in a statement.

"We fully share the vision of Caprion to provide cutting edge immune-monitoring solutions enabling the development of innovative immune and cell therapies," said Phoebe Bonner, CEO of Serametrix.

Financial and other details of the acquisition were not disclosed.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.